| Literature DB >> 32502552 |
Kwonil Jung1, Linda J Saif2, Qiuhong Wang3.
Abstract
Porcine epidemic diarrhea virus (PEDV), a member of the genus Alphacoronavirus in the family Coronaviridae, causes acute diarrhea and/or vomiting, dehydration and high mortality in neonatal piglets. Two different genogroups of PEDV, S INDEL [PEDV variant containing multiple deletions and insertions in the S1 subunit of the spike (S) protein, G1b] and non-S INDEL (G2b) strains were detected during the diarrheal disease outbreak in US swine in 2013-2014. Similar viruses are also circulating globally. Continuous improvement and update of biosecurity and vaccine strains and protocols are still needed to control and prevent PEDV infections worldwide. Although the non-S INDEL PEDV was highly virulent and the S INDEL PEDV caused milder disease, the latter has the capacity to cause illness in a high number of piglets on farms with low biosecurity and herd immunity. The main PEDV transmission route is fecal-oral, but airborne transmission via the fecal-nasal route may play a role in pig-to-pig and farm-to-farm spread. PEDV infection of neonatal pigs causes fecal virus shedding (alongside frequent detection of PEDV RNA in the nasal cavity), acute viremia, severe atrophic enteritis (mainly jejunum and ileum), and increased pro-inflammatory and innate immune responses. PEDV-specific IgA effector and memory B cells in orally primed sows play a critical role in sow lactogenic immunity and passive protection of piglets. This review focuses on the etiology, transmission, pathogenesis, and prevention and control of PEDV infection.Entities:
Keywords: Coronavirus; PEDV; Pathogenesis; Pigs; Porcine epidemic diarrhea virus; Prevention
Mesh:
Substances:
Year: 2020 PMID: 32502552 PMCID: PMC7266596 DOI: 10.1016/j.virusres.2020.198045
Source DB: PubMed Journal: Virus Res ISSN: 0168-1702 Impact factor: 3.303
Fig. 1Immunohistochemical detection and distribution of PEDV antigen-positive cells in the proximal jejunum, mid-jejunum, or distal jejunum of a gnotobiotic 9-day-old pig inoculated with the original US non-S INDEL PEDV strain PC21A. The pig exhibited vomiting (but no diarrhea) at post-inoculation hour (PIH) 16 and was euthanized. (A) Proximal jejunum distant by 15 cm from the pylorus, showing low numbers of PEDV antigen-positive cells (red color) in the villus-crypt interface (arrows). (B) Proximal jejunum distant by 30 cm from the pylorus, showing high numbers of PEDV antigen-positive cells (red color) in most of the villous epithelium. (C) Mid-jejunum [mid-location of the small intestine (duodenum to ileum)], showing extremely high numbers of PEDV antigen-positive cells (dark red color) in most of the epithelium of mildly atrophied villi. (D) Distal jejunum, showing moderate numbers of PEDV antigen-positive cells (red color) in the villus-crypt interface. Original magnification, all ×40. Fast Red, Gill’s hematoxylin counterstain.
Summary of clinical signs and fecal viral RNA shedding in conventional weaned and feeder pigs, and boars and sows experimentally infected with different genogroups of porcine epidemic diarrhea virus (PEDV) strains via oral inoculation, or direct or indirect aerosol contact.
| Pig | Age (days or years) at inoculation or exposure | PEDV strain and inoculum dose | Infection or exposure route | Onset of diarrhea (PID) | Duration of diarrhea (PID) | Onset of fecal viral RNA shedding (PID) | Duration of fecal viral RNA shedding | Peak viral RNA titers in feces or rectal swab fluids | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Weaned | 21 days | US non-S INDEL, USA/Iowa/18984/2013, 1 mL of 1 × 103 PFU/mL | Oral | PID 2 in 8/32 pigs (25 %) | PID 2−7 | PID 1 | Up to PID 24 | 4 × 104 PFU/mL at PID 4 | |
| Weaned | 21 days | US non-S INDEL, USA/IN19338/2013, 10 mL of 5.6, 56, or 560 TCID50/mL | Oral | PID 2 in 1/6 pigs (16.7 %) | PID 2−7 | PID 2 | Up to PID 21 | Approximately 5−7.5 log10 RNA copies/mL at PID 5−6 | |
| Weaned | 28 days | US non-S INDEL, USA/2014/Iowa, jejunal homogenate from infected pigs, 5 mL of 108 RNA copies/mL | Oral | PID 1 (2/2; 100 %) | NR | PID 1 | Up to PID 21 | 11.5 log10 RNA copies/mL at PID 2−3 | |
| Direct contact | PID 2 (6/8; 75 %) | PID 1−2 | Up to PID 42 | 11.1−11.4 log10 RNA copies/mL at PID 2−5 | |||||
| Indirect aerosol contact | PID 2 (8/10; 80 %) | NR (but with sporadic vomiting at PID 11−46) | PID 2 | Up to PID 49 | 10.5−12.2 log10 RNA copies/mL at PID 2−6 | ||||
| European S INDEL, FR/001/2014, jejunal homogenate from infected pigs, 5 mL of 108 RNA copies/mL | Oral | PID 4 | PID 4−25 (with sporadic vomiting and lethargy) | PID 2 | Up to PID 21 | 9.7−10.2 log10 RNA copies/mL at PID 4−6 | |||
| Direct contact | PID 4 | PID 4−14 | Up to PID 49 | 6.6−9.3 log10 RNA copies/mL at PID 6−21 | |||||
| Indirect aerosol contact | No clinical signs in 10 pigs (0/10) | No clinical signs | No fecal shedding | No fecal shedding | No fecal shedding | ||||
| Weaned to feeder | 28 days | US non-S INDEL, USA/KS/2013, 5 mL of 1.42 × 105 TCID50/mL | Oral | PID 3 | PID 3−8 | PID 2 | Up to PID 28 (1/12 pigs) | Titers not determined, but lowest Ct values in fecal and nasal swabs at PID 5−6 | |
| Direct contact | PID 3 | PID 3−8 | PID 3 (with nasal shedding at PID 2) | Up to PID 21 (2/5 pigs) | |||||
| Indirect aerosol contact | No clinical signs in 5 pigs (0/5) | No clinical signs | No fecal shedding | No fecal shedding | No fecal shedding | ||||
| Weaned to feeder | 35 days (5 weeks) | US non-S INDEL, jejunal homogenate from a pig in Iowa | Oral | PID 4 | NR | PID 1−2 | Up to PID 18 | Titers not determined, but lowest Ct values at PID 2−6 | |
| European, classical S INDEL, cell culture-grown Br1/87, 2 mL of 1 × 106.8 TCID50/mL | Oral | PID 4 | NR | PID 2−3 | Up to PID 18 | Titers not determined, but lowest Ct values at PID 3−8 | |||
| Feeder | 56 days (8 weeks) | US non-S INDEL, USA/Colorado/2013, 10 mL of 9 × 104 PFU/mL | Oral in feeder pigs | PID 2 in 3 of 40 pigs (7.5 %) | NR | PID 1 in 9 of 48 pigs (18.7 %) | At least up to PID 14 in 9/20 pigs (45.0 %) | NR | |
| Oral in nursing pigs | PID 1 in 2 of 43 pigs (4.6 %) | NR | PID 1 in 8 of 43 pigs (18.6 %) | At least up to PID 14 in 20/33 pigs (60.6%) | NR | ||||
| Boars | 1.5−2.5 years | US non-S INDEL, USA/2014/Iowa, jejunal homogenate from infected pigs, 5 mL | Oral | PID 2 | PID 2−5 and PID 25−28 (with vomiting at PID 2 and 11) | PID 2 | Up to PID 21−28 | 6.8 × 108 to 5.7 × 109 RNA copies/mL at PID 3−4 | |
| Sows | Multiparous sows | European S INDEL, German cell culture-grown strain, 6 mL of 3.16 × 105 TCID50/mL | Oral | No diarrhea | No diarrhea (but with slight depression in 2/2 sows for 4 days) | PID 4−5 | Up to PID 10−14 | NR | |
| European S INDEL, jejunal homogenate from a German pig | Oral | PID 1 (with vomiting) | NR | PID 4 | Up to PID 12−13 | NR | |||
| Gilts | Pregnant gilts | US non-S INDEL, PC22A, 1 × 105 PFU/pig | Oral | PID 2−4 | PID 2−6 | PID 2−4 | At least up to PID 14 | Approximately 8.5−10.0 log10 RNA copies/mL at PID 4−6 |
Note no mortality of PEDV-infected nursing, weaned, or feeder pigs reported in these studies.
TCID50, 50 % tissue culture infectious dose; PFU, plaque forming unit; PID, post-inoculation day.
NR, not reported.
Pregnant gilts were inoculated with PEDV at the early (day 19–22), middle (day 57–59), or late (day 96–97) gestation periods.
Summary of in vivo results from conventional or caesarean-derived, colostrum-deprived (CDCD) pigs inoculated orally with attenuated porcine epidemic diarrhea virus (PEDV) strains.
| Strain (cell passage number) | Genogroup | Dose per pig | Age of pigs inoculated | Animal number | Mortality (%) | Clinical signs | Fecal viral RNA shedding | Gross or histologic lesions | PEDV antigen in the intestine | Reference |
|---|---|---|---|---|---|---|---|---|---|---|
| 83P-5 (100th) | 1a (classical S INDEL) | 8.2 log10 TCID50 | 12-week | 4 | NR | No diarrhea at PID 1−14 | Intermittent detection of viral RNA in the feces of 3/5 pigs at PID 3−9 | NR | NR | |
| YN144 (144th) | 2b (non-S INDEL) | 6 log10 TCID50 | 10-day | 4 | NR | No diarrhea at PID 1−5 | No detection [possibly due to no necrosis of virus-infected (antigen-positive) enterocytes, as claimed by the authors] at PID 1 and 5 | No gross lesions at PID 5 | Low to moderate numbers of positive enterocytes lining the villous epithelium at PID 5 | |
| PEDV 8aa (70th) (with GCDCA) | 2b (non-S INDEL) | 6 log10 TCID50 | 1-day | 15 | 0 at PID 1−14 | Loose stool at PID 1−2, as monitored at PID 1−14 | No or little viral RNA shedding at PID 1−14 | NR | NR | |
| PEDV 8aa (105th) (with GCDCA) | 2b (non-S INDEL) | 6 log10 TCID50 | 1-day | 16 | 0 at PID 1−14 | No diarrhea at PID 1−14 | No or little viral RNA shedding at PID 1−14 | NR | NR | |
| PC22A (120th) | 2b (non-S INDEL) | 2 log10 PFU | 4-day CDCD | 6 | 0 at PID 1−10 or 15 | Mild diarrhea in 3/4 pigs (75 %) at PID 1−10 or 15 | High (with mean peak viral RNA shedding titer of 10.19 log10 GE/mL) | Moderate villous atrophy at PID 9 (mean VH:CD ratio of 3.6 | Low numbers of positive enterocytes lining the villous epithelium at PID 9 | |
| PC22A (140th) | 2b (non-S INDEL) | 2 log10 PFU | 4-day CDCD | 6 | 0 at PID 1−10 or 15 | Loose stool in 2/4 pigs (50 %) at PID 1−10 or 15 | Moderate (with mean peak viral RNA shedding titer of 7.65 log10 GE/mL), as tested at PID 1−10 or 15 | Mild villous atrophy at PID 9 (mean VH:CD ratio of 5.0 | No detection of PEDV antigen at PID 9 | |
| PC22A (160th) | 2b (non-S INDEL) | 2 log10 PFU | 4-day CDCD | 7 | 0 at PID 1−10 or 15 | Loose stool in 2/5 pigs (40 %) at PID 1−10 or 15 | Low (with mean peak viral RNA shedding titer of 5.00 log10 GE/mL), as tested at PID 1−10 or 15 | Mild villous atrophy at PID 9 (mean VH:CD ratio of 5.2 | No detection of PEDV antigen at PID 9 | |
| CT (120th) | 2b (non-S INDEL) | 6 log10 TCID50 | 6-day | 5−6 | 0 at PID 1−10 | Loose stool in some pigs at PID 4−5, at monitored at PID 1−10 | Moderate (with mean peak viral RNA shedding titer of approximate 6−7 log10 GE/mL at PID 4−5), as tested at PID 1−10 | Mild villous atrophy in a pig at PID 3 | No or little detection of PEDV antigen in a pig at PID 3 |
TCID50, 50 % tissue culture infectious dose; PFU, plaque forming unit; PID, post-inoculation day; GE, genome equivalents; VH:CD ratio, villous height to crypt depth ratio.
NR, not reported.
Among PEDV strains, only PEDV 8aa was grown in Vero cells treated with glycochenodeoxycholic acid (GCDCA) instead of trypsin.
Fig. 2Histologic (A and B) and immunohistochemical (C) localization of mammary IgA-secreting cells, and expression of mucosal addressin cellular adhesion molecule 1 (MAdCAM-1) (D) and chemokine ligand 25 (CCL25) (E) by immunofluorescent (IF) staining in the mammary gland tissue of PEDV naïve gilts. (A) Hematoxylin and eosin–stained mammary gland tissue of a gilt at 4 days post-farrowing, showing fully expanded alveoli, with mostly empty lumens. (B) Higher magnification of Panel A (inset), showing clusters of plasma cells characterized by the typical peripheral nuclei in the abundant cytoplasm in the interlobular stroma. Original magnification, ×200 (A) and ×400 (B). (C) Immunohistochemistry (IHC)-stained mammary gland tissue of a gilt at 5 days post-farrowing, showing a moderate number of IgA-positive cells (dark brown) in the intralobular or interlobular stroma (arrows). Original magnification, ×200. IHC was done using a polyclonal goat antibody to pig IgA conjugated with peroxidase (Bio-RAD) and DAB substrate. (D) IF-stained mammary gland tissue of a gilt at 4 days pre-farrowing, showing moderate expression of MAdCAM-1 (green) on the endothelial cells lining the intralobular and interlobular vessels (arrows). Original magnification, ×200. (E) IF-stained mammary gland tissue of a gilt at 4 days post-farrowing, showing moderate expression of CCL25 (green) on the endothelial cells lining the intralobular and interlobular vessels (arrows). Original magnification, ×200. IF staining was done using monoclonal antibodies against human MAdCAM-1 and CCL25 (Novus Biologicals).